Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated

Journal of Clinical Microbiology

Volumn 41, Issue 6, 2003, Pages 2763-2767

  Weissenborn, S J ^a   Funke, A M ^a   Hellmich, M ^a   Mallmann, P ^a   Fuchs, P G ^a   Pfister, H J ^a   Wieland, U ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS LOAD; WART VIRUS;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0038518244     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.6.2763-2767.2003     Document Type: Article

References (47)

1. Ahdieh, L., R. S. Klein, R. Burk, S. Cu-Uvin, P. Schuman, A. Duerr, M. Safaeian, J. Astemborski, R. Daniel, and K. Shah. 2001. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J. Infect. Dis. 184:682-690.
2. Bauer, H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. J. Tashiro, J. Chimera, A. Reingold, and M. M. Manos. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
3. Bavin, P. J., J. A. Giles, A. Deery, J. Crow, P. D. Griffiths, V. C. Emery, and P. G. Walker. 1993. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br. J. Cancer 67:602-605.
4. Beaudenon, S., D. Kremsdorf, O. Croissant, S. Jablonska, S. Wain-Hobson, and G. Orth. 1986. A novel type of human papillomavirus associated with genital neoplasias. Nature 321:246-249.
5. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
6. Boshart, M., L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, and H. H. zur Hausen. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3:1151-1157.
7. Cardillo, M., R. Hagan, J. Abadi, and M. A. Abadi. 2001. CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. Cancer 93:111-114.
8. Centers for Disease Control and Prevention. 1993. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269:729-730.
9. Conti, M., A. Agarossi, F. Parazzini, M. L. Muggiasca, A. Boschini, E. Negri, and E. Casolati. 1993. HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol. Oncol. 49:344-348.
10. Crowley-Nowick, P. A., J. H. Ellenberg, S. H. Vermund, S. D. Douglas, C. A. Holland, and A. B. Moscicki. 2000. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J. Infect. Dis. 181:939-945.
11. Cuzick, J., G. Terry, L. Ho, T. Hollingworth, and M. Anderson. 1992. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia. Lancet 339:959-960.
12. Delius, H., and B. Hofmann. 1994. Primer-directed sequencing of human papillomavirus types. Curr. Top. Microbiol. Immunol. 186:13-31.
13. Delmas, M. C., C. Larsen, B. van Benthem, F. F. Hamers, C. Bergeron, J. D. Poveda, B. Anzen, A. van den Hoek, F. Meier, J. M. Pena, H. Savonius, D. Sperandeo, B. Suligoi, P. Vernazza, J. B. Brunet, et al. 2000. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. AIDS 14:1775-1784.
14. Dolei, A., S. Curelli, P. Marongiu, A. Pierangeli, E. Gomes, M. Bucci, C. Serra, and A. M. Degener. 1999. Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. J. Gen. Virol. 80:2937-2944.
15. Ellerbrock, T. V., M. A. Chiasson, T. J. Bush, X. W. Sun, D. Sawo, K. Brudney, and T. C. Wright. 2000. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283:1031-1037.
16. Flannelly, G., G. Jiang, D. Anderson, W. Melvin, E. Mann, and H. Kitchener. 1995. Serial quantitation of HPV-16 in the smears of women with mild and moderate dyskaryosis. J. Med. Virol. 47:6-9.
17. Fleiss, J. L. 1961. Statistical methods for rates and proportions. John Wiley & Sons, New York, N.Y.
18. Frisch, M., R. J. Biggar, and J. J. Goedert. 2000. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Natl. Cancer Inst. 92:1500-1510.
19. Frisch, M., R. J. Biggar, E. A. Engels, and J. J. Goedert. 2001. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736-1745.
20. Heard, I., J. M. Tassie, V. Schmitz, L. Mandelbrot, M. D. Kazatchkine, and G. Orth. 2000. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet. Gynecol. 96:403-409.
21. Holoway, P., A. B. Miller, T. Rohan, and T. To. 1999. Natural history of dysplasia of the uterine cervix. J. Natl. Cancer Inst. 91:252-258.
22. Jacobs, M. V., P. J. F. Snijders, A. J. C. van den Brule, T. J. M. Helmerhorst, C. J. L. M. Meijer, and J. M. M. Walboomers. 1997. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35:791-795.
23. Josefsson, A. M., P. K. Magnusson, N. Ylitalo, P. Sorensen, P. Qwarforth-Tubbin, P. K. Andersen, M. Melbye, H. O. Adami, and U. B. Gyllensten. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355:2189-2193.
24. Kurman, R. J., D. E. Henson, A. L. Herbst, K. L. Noller, M. H. Schiffman, et al. 1994. Interim guidelines for management of abnormal cervical cytology. JAMA 271:1866-1869.
25. Lorincz, A. T., W. D. Lancaster, and G. F. Temple. 1986. Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J. Virol. 58:225-229.
26. Lorincz, A. T., P. E. Castle, M. E. Sherman, D. R. Scott, A. G. Glass, S. Wacholder, B. B. Rush, P. E. Gravitt, J. E. Schussler, and M. Schiffman. 2002. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228-229.
27. Luff, R. D., et al. 1992. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. Hum. Pathol. 23:719-721.
28. Luque, A. E., L. M. Demeter, and R. C. Reichman. 1999. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection. J. Infect. Dis. 179:1405-1409.
29. Maiman, M., R. G. Fruchter, A. Sedlis, J. Feldman, P. Chen, R. D. Burk, and H. Minkoff. 1998. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol. Oncol. 68:233-239.
30. Massad, L. S., K. A. Riester, K. M. Anastos, R. G. Fruchter, J. M. Palefsky, R. D. Burk, D. Burns, R. M. Greenblatt, L. I. Muderspach, P. Miotti, et al. 1999. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. J. Acquir. Immune Defic. Syndr. 21:33-41.
31. Naghashfar, Z. S., N. B. Rosenshein, A. T. Lorincz, J. Buscema, and K. V. Shah. 1987. Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. J. Gen. Virol. 68:3073-3079.
32. Ostor, A. G. 1993. Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol. 12:186-192.
33. Palefsky, J. M. 1998. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J. Natl. Cancer Inst. 23:15-20.
34. Palefsky, J. M., H. Minkoff, L. A. Kalish, A. Levine, H. S. Sacks, P. Garcia, M. Young, S. Melnick, P. Miotti, and R. Burk. 1999. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J. Natl. Cancer Inst. 91:226-236.
35. Schmitt, J., J. R. Schlehofer, K. Mergener, L. Gissmann, and H. zur Hausen. 1989. Amplification of bovine papillomavirus DNA by N-methyl-N-nitro-N-nitrosoguanidine, ultraviolet irradiation, or infection with herpes simplex virus. Virology 172:73-81.
36. Scott, M., M. Nakagawa, and A. B. Moscicki. 2001. Cell-mediated immune response to human papillomavirus infection. Clin. Diagn. Lab. Immunol. 8:209-220.
37. Seedorf, K., G. Krammer, M. Durst, S. Suhai, and W. G. Rowekamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
38. Serraino, D., P. Carrieri, C. Pradier, E. Bidoli, M. Dorrucci, E. Ghetti, A. Schiesari, R. Zucconi, P. Pezzotti, P. Dellamonica, S. Franceschi, and G. Rezza. 1999. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int. J. Cancer 82:334-337.
39. Six, C., I. Heard, C. Bergeron, G. Orth, J. D. Poveda, P. Zagury, P. Cesbron, C. Crenn-Hebert, R. Pradinaud, M. Sobesky, C. Marty, M. L. Babut, J. E. Malkin, A. Odier, S. Fridmann, J. P. Aubert, J. B. Brunet, and I. de Vincenzi. 1998. Comparative prevalence, incidence, and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 12:1047-1056.
40. Soost, H. J., S. Baur, and H. Smolka. 1990. Gynaekologische Zytodiagnostik. Thieme, Stuttgart, Germany.
41. Swan, D. C., R. A. Tucker, G. Tortolero-Luna, M. F. Mitchell, L. Wideroff, E. R. Unger, R. A. Nisenbaum, W. C. Reeves, and J. P. Icenogle. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1030-1034.
42. van Duin, M., P. J. Snijders, H. F. Schrijnemakers, F. J. Voorhorst, L. Rozendaal, M. A. Nobbenhuis, A. J. van den Brule, R. H. Verheijen, T. J. Helmerhorst, and C. J. Meijer. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int. J. Cancer 98:590-595.
43. Vernon, S. D., C. E. Hart, W. C. Reeves, and J. P. Icenogle. 1993. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res. 27:133-145.
44. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
45. Wieland, U., S. Jurk, S. Weissenborn, T. Krieg, H. Pfister, and A. Ritzkowsky. 2000. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J. Investig. Dermatol. 115:396-401.
46. Ylitalo, N., P. Sorensen, A. M. Josefsson, P. K. Magnusson, P. K. Andersen, J. Ponten, H. O. Adami, U. B. Gyllensten, and M. Melbye. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355:2194-2198.
47. zur Hausen, H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.